pyrazole has been researched along with Leishmaniasis, Cutaneous in 1 studies
1H-pyrazole : The 1H-tautomer of pyrazole.
Leishmaniasis, Cutaneous: An endemic disease that is characterized by the development of single or multiple localized lesions on exposed areas of skin that typically ulcerate. The disease has been divided into Old and New World forms. Old World leishmaniasis is separated into three distinct types according to epidemiology and clinical manifestations and is caused by species of the L. tropica and L. aethiopica complexes as well as by species of the L. major genus. New World leishmaniasis, also called American leishmaniasis, occurs in South and Central America and is caused by species of the L. mexicana or L. braziliensis complexes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Faiões, Vdos S | 1 |
| Dos Santos, MS | 1 |
| Bernardino, AM | 1 |
| Cunha-Júnior, EF | 1 |
| Canto Cavalheiro, MM | 1 |
| Torres-Santos, EC | 1 |
1 other study available for pyrazole and Leishmaniasis, Cutaneous
| Article | Year |
|---|---|
The new pyrazolyltetrazole derivative MSN20 is effective via oral delivery against cutaneous leishmaniasis.
Topics: Administration, Oral; Animals; Antiprotozoal Agents; Inhibitory Concentration 50; Leishmaniasis, Cut | 2014 |